HilleVax, Inc.
HLVX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $102 | $652 | $630 | $576 |
| - Cash | $154 | $217 | $279 | $125 |
| + Debt | $25 | $51 | $36 | $158 |
| Enterprise Value | -$28 | $486 | $387 | $610 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$2 | -$2 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$155 | -$132 | -$65 | -$100 |
| % Margin | – | – | – | – |
| Net Income | -$147 | -$124 | -$257 | -$85 |
| % Margin | – | – | – | – |
| EPS Diluted | -3 | -3.04 | -6.83 | -2.82 |
| % Growth | 1.3% | 55.5% | -142.2% | – |
| Operating Cash Flow | -$109 | -$87 | -$62 | -$7 |
| Capital Expenditures | -$1 | -$11 | -$7 | -$3 |
| Free Cash Flow | -$109 | -$98 | -$69 | -$10 |